Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SBS 147

Next Previous
Drug Profile

SBS 147

Alternative Names: SBS-147

Latest Information Update: 18 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sparian Biosciences
  • Class Amides; Analgesics; Aromatic hydrocarbons; Epoxy compounds
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Pain

Most Recent Events

  • 08 Jan 2026 Phase-I clinical trials in Pain (In volunteers) in USA (PO) (NCT07335913)
  • 12 Nov 2024 Sparian Biosciences announces intention to submit IND for a combined phase I SAD/MAD trial this time next year
  • 21 Feb 2023 Preclinical trials in Pain in USA (PO) (Sparian Biosciences pipeline, February 2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top